Logo image of MARP.MI

MARZOCCHI POMPE SPA (MARP.MI) Stock Fundamental Analysis

BIT:MARP - Euronext Milan - IT0004376858 - Common Stock - Currency: EUR

2.8  -0.04 (-1.41%)

Fundamental Rating

4

Taking everything into account, MARP scores 4 out of 10 in our fundamental rating. MARP was compared to 105 industry peers in the Machinery industry. Both the profitability and the financial health of MARP get a neutral evaluation. Nothing too spectacular is happening here. MARP has a valuation in line with the averages, but on the other hand it scores bad on growth. Finally MARP also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

MARP had positive earnings in the past year.
In the past year MARP had a positive cash flow from operations.
Each year in the past 5 years MARP has been profitable.
MARP had a positive operating cash flow in each of the past 5 years.
MARP.MI Yearly Net Income VS EBIT VS OCF VS FCFMARP.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M 8M

1.2 Ratios

MARP has a Return On Assets of 4.24%. This is in the better half of the industry: MARP outperforms 67.31% of its industry peers.
MARP has a Return On Equity of 9.65%. This is in the better half of the industry: MARP outperforms 67.31% of its industry peers.
MARP has a Return On Invested Capital of 7.71%. This is in the better half of the industry: MARP outperforms 69.23% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MARP is in line with the industry average of 8.45%.
The 3 year average ROIC (7.60%) for MARP is below the current ROIC(7.71%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.24%
ROE 9.65%
ROIC 7.71%
ROA(3y)4.22%
ROA(5y)2.71%
ROE(3y)10.1%
ROE(5y)6.53%
ROIC(3y)7.6%
ROIC(5y)N/A
MARP.MI Yearly ROA, ROE, ROICMARP.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20 25

1.3 Margins

MARP's Profit Margin of 4.91% is fine compared to the rest of the industry. MARP outperforms 62.50% of its industry peers.
In the last couple of years the Profit Margin of MARP has declined.
MARP's Operating Margin of 6.94% is in line compared to the rest of the industry. MARP outperforms 59.62% of its industry peers.
MARP's Operating Margin has been stable in the last couple of years.
MARP has a better Gross Margin (49.07%) than 67.31% of its industry peers.
MARP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.94%
PM (TTM) 4.91%
GM 49.07%
OM growth 3YN/A
OM growth 5Y-0.19%
PM growth 3Y107.78%
PM growth 5Y-2.5%
GM growth 3Y-0.03%
GM growth 5Y-0.91%
MARP.MI Yearly Profit, Operating, Gross MarginsMARP.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

MARP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for MARP has been reduced compared to 1 year ago.
Compared to 5 years ago, MARP has more shares outstanding
Compared to 1 year ago, MARP has a worse debt to assets ratio.
MARP.MI Yearly Shares OutstandingMARP.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
MARP.MI Yearly Total Debt VS Total AssetsMARP.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

MARP has an Altman-Z score of 2.15. This is not the best score and indicates that MARP is in the grey zone with still only limited risk for bankruptcy at the moment.
MARP's Altman-Z score of 2.15 is in line compared to the rest of the industry. MARP outperforms 54.81% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that MARP is not too dependend on debt financing.
MARP's Debt to Equity ratio of 0.10 is amongst the best of the industry. MARP outperforms 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 2.15
ROIC/WACC1.16
WACC6.64%
MARP.MI Yearly LT Debt VS Equity VS FCFMARP.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 1.70 indicates that MARP should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.70, MARP is in line with its industry, outperforming 59.62% of the companies in the same industry.
A Quick Ratio of 1.09 indicates that MARP should not have too much problems paying its short term obligations.
The Quick ratio of MARP (1.09) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.09
MARP.MI Yearly Current Assets VS Current LiabilitesMARP.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for MARP have decreased strongly by -29.47% in the last year.
MARP shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.84% yearly.
The Revenue has decreased by -9.07% in the past year.
The Revenue has been growing slightly by 3.09% on average over the past years.
EPS 1Y (TTM)-29.47%
EPS 3Y125.8%
EPS 5Y-4.84%
EPS Q2Q%-37.38%
Revenue 1Y (TTM)-9.07%
Revenue growth 3Y13.37%
Revenue growth 5Y3.09%
Sales Q2Q%-17.31%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MARP.MI Yearly Revenue VS EstimatesMARP.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MARP.MI Yearly EPS VS EstimatesMARP.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 0.1 0.2 0.3 0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

MARP is valuated reasonably with a Price/Earnings ratio of 8.24.
90.38% of the companies in the same industry are more expensive than MARP, based on the Price/Earnings ratio.
MARP is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.24
Fwd PE N/A
MARP.MI Price Earnings VS Forward Price EarningsMARP.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MARP indicates a rather cheap valuation: MARP is cheaper than 80.77% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.88
MARP.MI Per share dataMARP.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

MARP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

7

5. Dividend

5.1 Amount

MARP has a Yearly Dividend Yield of 7.14%, which is a nice return.
The stock price of MARP dropped by -30.35% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
MARP's Dividend Yield is rather good when compared to the industry average which is at 3.07. MARP pays more dividend than 100.00% of the companies in the same industry.
MARP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 7.14%

5.2 History

The dividend of MARP is nicely growing with an annual growth rate of 35.72%!
Dividend Growth(5Y)35.72%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

58.57% of the earnings are spent on dividend by MARP. This is a bit on the high side, but may be sustainable.
MARP's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP58.57%
EPS Next 2YN/A
EPS Next 3YN/A
MARP.MI Yearly Income VS Free CF VS DividendMARP.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M 8M 10M
MARP.MI Dividend Payout.MARP.MI Dividend Payout, showing the Payout Ratio.MARP.MI Dividend Payout.PayoutRetained Earnings

More info and screens

MARZOCCHI POMPE SPA

BIT:MARP (3/4/2025, 7:00:00 PM)

2.8

-0.04 (-1.41%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.52%
Inst Owner ChangeN/A
Ins Owners4.7%
Ins Owner ChangeN/A
Market Cap18.31M
Analysts82.86
Price Target8.67 (209.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.14%
Yearly Dividend0.15
Dividend Growth(5Y)35.72%
DP58.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.24
Fwd PE N/A
P/S 0.41
P/FCF N/A
P/OCF 30.65
P/B 0.8
P/tB 0.82
EV/EBITDA 4.88
EPS(TTM)0.34
EY12.14%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)0.09
OCFY3.26%
SpS6.9
BVpS3.51
TBVpS3.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.24%
ROE 9.65%
ROCE 9.82%
ROIC 7.71%
ROICexc 9.37%
ROICexgc 9.63%
OM 6.94%
PM (TTM) 4.91%
GM 49.07%
FCFM N/A
ROA(3y)4.22%
ROA(5y)2.71%
ROE(3y)10.1%
ROE(5y)6.53%
ROIC(3y)7.6%
ROIC(5y)N/A
ROICexc(3y)10.57%
ROICexc(5y)N/A
ROICexgc(3y)11.05%
ROICexgc(5y)N/A
ROCE(3y)9.69%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y13.3%
ROICexc growth 3YN/A
ROICexc growth 5Y12.84%
OM growth 3YN/A
OM growth 5Y-0.19%
PM growth 3Y107.78%
PM growth 5Y-2.5%
GM growth 3Y-0.03%
GM growth 5Y-0.91%
F-Score4
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 0.35
Cap/Depr 108.99%
Cap/Sales 7.67%
Interest Coverage 250
Cash Conversion 9.47%
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.09
Altman-Z 2.15
F-Score4
WACC6.64%
ROIC/WACC1.16
Cap/Depr(3y)60.37%
Cap/Depr(5y)56.72%
Cap/Sales(3y)5.28%
Cap/Sales(5y)5.98%
Profit Quality(3y)56.58%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.47%
EPS 3Y125.8%
EPS 5Y-4.84%
EPS Q2Q%-37.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.07%
Revenue growth 3Y13.37%
Revenue growth 5Y3.09%
Sales Q2Q%-17.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.79%
EBIT growth 3YN/A
EBIT growth 5Y2.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-357.59%
FCF growth 3Y-39.8%
FCF growth 5Y-34.8%
OCF growth 1Y-43.95%
OCF growth 3Y-13.28%
OCF growth 5Y-17.14%